Abiopharma

Ginkgo Bioworks - Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

(30% Negative) MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Reports Q2 2026 Financial Results

Director Norsa Michele 🔴 sold 4.0K shares of Ermenegildo Zegna N.V. (ZGN) at $11.87 Transaction Date: May 05, 2026 | Filing ID: 000005

(10% Negative) ATHIRA PHARMA, INC. (LONA) Announces Delay in Lasofoxifene Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(30% Negative) NANO DIMENSION LTD. (NNDM) Reports Q2 2026 Financial Results

Guardant Health, Inc. - Guardant Health Reports First Quarter 2026 Financial Results and Increases 2026 Revenue Guidance

Director LESJAK CATHERINE A 🟢 acquired 678 shares of GENERAL ELECTRIC CO (GE) Transaction Date: May 05, 2026 | Filing ID: 000002

Profound Medical Reports Strong First Quarter 2026 Financial Results

(99% Neutral) RED RIVER BANCSHARES INC (RRBI) Files Form 8-K

Director Kissel Mary E. 🟡 adjusted position in 9.3K shares (2 derivative) of QXO, Inc. (QXO) Transaction Date: May 05, 2026 | Filing ID: 000009

(10% Negative) ANNEXON, INC. (ANNX) Reports Q2 2026 Financial Results

Director HORTON THOMAS W 🟢 acquired 678 shares of GENERAL ELECTRIC CO (GE) Transaction Date: May 05, 2026 | Filing ID: 000002

📋 KATHY WEILER (Director) plans to sell 16K shares of AXOGEN, INC. (at $44.09 each, total $721K) Filed: May 07, 2026 | ID: 004178

Perry James E 🟢 acquired 1.8K shares (1 derivative) of CSW INDUSTRIALS, INC. (CSW) Transaction Date: May 06, 2026 | Filing ID: 000004

Adkins Christopher A 🟡 adjusted position in 1.4K shares of ARCBEST CORP /DE/ (ARCB) at $118.17 Transaction Date: May 05, 2026 | Filing ID: 000003